Market Alert: Global Equity Markets Under Pressure Amid Valuation Concerns and Economic Uncertainty

BrainChip Announces AU$35 Million Placement and SPP to Accelerate Edge AI Growth

Nov 10, 2025

BrainChip Holdings Ltd (ASX: BRN), has announced a fully underwritten institutional placement of AU$35 million and a non-underwritten Share Purchase Plan (SPP) to raise up to an additional AU$2 million. The capital raising, priced at AU$0.175 per share—a discount to recent market levels—will accelerate the commercialisation of the Akida™ 2.0 neuromorphic platform and advance the development of edge AI and generative AI technologies.

Proceeds will fund R&D for TENNs algorithms, Pico devices, and next-generation chip architecture, as well as strengthen working capital and operational support. CEO Sean Hehir said the raise empowers BrainChip to drive leadership in edge AI and deliver transformative on-device intelligence. Managed by Unified Capital Partners and Morgans Corporate, the initiative strategically positions BrainChip to scale in high-growth sectors including defense, healthcare, and wearables while reinforcing its edge in neuromorphic computing innovation.

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com